Paloma Carrillo

Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0

Liu W, Li-You Lian, Seung Up Kim, Terry Cheuk‐Fung Yip et autres

INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease, and liver biopsy remains the gold standard for diagnosis. However, a subset of patients diagnosed with MASLD by imaging paradoxically exhibit steatosis grade S0 on liver biopsy, posing a …

cn, kr, hk, ar, it, jp, gb, my, fr, tr, se, es, sa, in, us, sg, au, jo, Égypte (code pays fourni par la source)

SAT-244 Dysregulation of the urea cycle enzymes determines a more severe MASLD phenotype in a DIAMOND preclinical model

Carola Zurita Palomo, Rocío Gallego-Durán, Douglas Maya-Miles, Lucía López-Bermudo et autres

THU-108 Supervised physical activity improves muscle qualityand function in MASLD: insights from the EHMet-DIA study

Paloma Carrillo, Miguel Angel Fernandez, Ignacio Torrescusa Buzo, Lucía López-Bermudo et autres

WED-069 Optimizing hepatocellular cancer surveillance in metabolic dysfunction–associated steatotic liver disease based on liver stiffness measurement

Luis Calzadilla Bertot, Stuart K. Roberts, Javier Ampuero, Javier Crespo et autres

WED-153 Accuracy of non-invasive tests for ruling out or in advanced fibrosis in MASLD patients across clinical settings: a systematic review and meta-analysis

Douglas Maya-Miles, Evangelia Mentsiou-Nikolaou, Isabel Fernández-Lizaranzu, Fariba Ahmadizar et autres

Pathophysiology of metabolic dysfunction associated steatotic liver disease

Jordi Gracia-Sancho, Paloma Carrillo, Rocío Gallego-Durán

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver pathology worldwide, affecting more than one-third of the general population.Its pathophysiology is complex and multifactorial, involving metabolic, immunological, genetic, and environmental alterations that interact synergistically to determine the patient's phenotype.This review …

es (code pays fourni par la source)

Progression of Liver Fibrosis and Liver-Related Event Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease at High Cardiovascular Risk

X Z Zhou, Qin-Fen Chen, Seung Up Kim, Terry Cheuk-Fung Yip et autres

cn, kr, hk, it, jp, gb, fr, se, my, es, us, sg (code pays fourni par la source)

Fisiopatología de la enfermedad hepática asociada a disfunción metabólica

Jordi Gracia-Sancho, Paloma Carrillo, Rocío Gallego-Durán

La enfermedad hepática asociada a disfunción metabólica (MASLD, Metabolic dysfunction Associated Steatotic Liver Disease) constituye la patología hepática de mayor prevalencia en todo el mundo, afectando a más de un tercio de la población general.Su fisiopatología es compleja y multifactorial, pues involucra …

es (code pays fourni par la source)

Phenotype-Specific Mitochondrial Responses to Mediterranean Diet and Exercise in Elderly Obesity

Paloma Carrillo, María Ángeles Silva-Soto, Rocío Gallego‐Durán, Elena Medina-Jiménez et autres

Background/Objectives: While excessive body fat is commonly linked to metabolic disorders (metabolically unhealthy obesity, MUO), a subset of individuals remain metabolic healthy despite obesity (metabolically healthy obesity, MHO). This work aims to determine how these phenotypes influence responses to lifestyle modification (LSM) …

es (code pays fourni par la source)

LA ACTIVIDAD FÍSICA SUPERVISADA MEJORA LA CALIDAD Y LA FUNCIÓN MUSCULAR EN LA ENFERMEDAD HEPÁTICA ESTEATÓSICA ASOCIADA A DISFUNCIÓN METABÓLICA (MASLD): HALLAZGOS DEL ESTUDIO EHMET-DIA

Paloma Carrillo, Miguel Ángel Fernández-Gómez, Ignacio Torrescusa-Buzo, Lucía López-Bermudo et autres

86 - ALTERNATIVA PREDICTIVA A LA ELASTOGRAFÍA POR RESONANCIA MAGNÉTICA: UN NUEVO BIOMARCADOR PARA LA EVALUACIÓN NO INVASIVA DE EHMET

Isabel Fernández-Lizaranzu, Pedro Montero-Pavón, Vanessa García-Fernández, Paloma Carrillo et autres

Cardiovascular–kidney–metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD

Xiaodong Zhou, Qin‐Fen Chen, Qi Wen Fan, Seung Up Kim et autres

BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome, a new framework integrating cardiovascular, renal, and metabolic dysfunction, remains inadequately characterized in metabolic dysfunction-associated steatotic liver disease (MASLD). OBJECTIVE: We investigated the relationships between CKM stages and liver fibrosis severity, progression, and the risk of liver-related events …

cn, kr, hk, it, jp, gb, fr, se, my, es, us, sg (code pays fourni par la source)